Cramer’s lightning round: Amicus Therapeutics is an ideal spec

Cramer’s lightning round: Amicus Therapeutics is an ideal spec

Cramer answered callers’ investing questions at rapid speed on Tuesday.

as per our monitoring this Story originally appeared on

*CNBC Television*

Cramer’s lightning round: Amicus Therapeutics is an ideal spec

Have A Say ?

Pay A Visit : CNBC Television Story

Hi Viewer of this Story,

You may add your Story ;

Visit & Add: SocialStory

Add your News,
Views,
Consciences,
Etc.
as Story

Story starts here